The Short PeptideWritten for a single organ

The question

How short can a message be and still change what happens next?

New to peptides? Start here.

Three short steps, no biology degree needed. Each one links to a full guide when you want more.

  1. 1

    What’s a peptide?

    A peptide is a short chain of amino acids, the same building blocks that make up protein. Many of your body’s own peptides work as messages between cells.

    → What are peptides, really?(coming soon)

  2. 2

    How genes get switched on

    Almost every cell has the same DNA. What makes a liver cell different from a brain cell is which genes it switches on and off, and that part is well-understood textbook biology.

    → How genes get switched on and off(coming soon)

  3. 3

    What bioregulators are, and what’s proven

    Bioregulators are very short peptides, often just two to four amino acids, that a Russian research group proposed can help steer gene activity organ by organ. That idea is still a hypothesis: the evidence is mostly from cells and animals, comes largely from one research group, and hasn’t been tested in large independent human trials.

    → What are peptide bioregulators?(coming soon)

Not sure how much to trust a study? → How to read peptide research(coming soon)

Words to know

Why this exists

Peptides have become confusing. We are here to make them plain.

One word now covers a dozen unrelated things. We read the papers, translate the findings, and hand you the knowledge in ordinary English — whether it's grounded theory or empirically validated results.

From a hand down to a four-letter chain

  1. 1 metre

    A hand

    Start at the size of a person. Everything below happens without you noticing any of it.

  2. 1 millimetre

    Skin, then tissue

    Tissue is not one thing. It is a crowd of cells, each reading its own instructions.

  3. 10 micrometres

    One cell

    Inside, DNA is stored wound and mostly closed. What gets read is a question of access.

  4. 1 nanometre

    A four-letter chain

    This is a short peptide. Two to four amino acids — small enough to reach places a protein cannot, short enough to carry almost no information. That is the puzzle.

The word “peptide” is doing too much work

Everything on this site sits in the left-hand column.

What we mean

  • Two to four amino acids
  • Assigned to one tissue
  • Taken by mouth
  • Pulsed, then stopped

What we do not mean

  • GLP-1 drugs
  • BPC-157, TB-500, KPV, GHRPs
  • Research vials and injectables
  • Spermidine, NAD+, resveratrol

New studies, explained

Latest Research

New and notable studies, explained in plain language. Each card covers what the researchers did, what they found, and what it does and doesn't mean, along with an evidence label so you can see how strong the finding is at a glance. Cards are grouped by body system. Open any card for the full breakdown.

Full library
  • Proposed
  • Modeled
  • Cell evidence
  • Animal evidence
  • Small or uncontrolled human data
  • Established in humans

Weakest on the left, strongest on the right. How to read peptide research(coming soon)

Heart & blood vessels

  • Established in humans

    A large trial tested the peptide drug semaglutide on heart attacks and strokes in people with heart disease

    What they did
    About 17,600 adults with existing heart or blood-vessel disease and overweight or obesity, but no diabetes, were randomly assigned to semaglutide (a GLP-1 drug) or a placebo. The researchers followed them and counted heart-related deaths, heart attacks, and strokes.
    What they found
    The semaglutide group had about one-fifth fewer of those events than the placebo group.
    What it does and doesn’t mean

    ✔It's a clear example of a peptide medicine tested the hard way: randomized, with a placebo, in thousands of people, counting outcomes that matter.

    ✘It applies to that drug, in that group of people. It isn't evidence for research peptides or for bioregulators, which work differently and haven't had trials like this. Like any strong drug, semaglutide has side effects, mostly stomach and gut related.

    + Study details

    Study type · Year · PMID
    Randomized, placebo-controlled outcome trial (SELECT) · 2023 · PMID 37952131 (NEJM)

    Full breakdown → What are peptides, really?(coming soon)2023

The organ map

Browse all organs

A recurring index, one tissue at a time. Each entry collects the short peptides assigned to that organ and the papers we have read.

For a deeper dig

But what about the science?

The detail behind the short version: history, chemistry, and the papers themselves.

The archive

Fifty years of work, published in the wrong language

  1. 1970s

    Leningrad

    Military medical work on organ extracts begins. Published in Russian, read almost nowhere else.

  2. 1980s–90s

    Extracts

    Thymalin, Epithalamin. Bovine-derived preparations, studied in clinical settings. [source needed]

  3. 2000s

    Synthetics

    Short synthetic chains — Epitalon, Vilon, Vesugen — designed to reproduce the extracts' activity.

  4. 2024

    The line ends

    Vladimir Khavinson, who led the programme, died in January 2024. We never worked with him.

Extract preparations and synthetic peptides are not interchangeable. Findings from a bovine extract do not transfer to a cheap synthetic chain, and we do not carry them across.

How we grade what you are about to read

Where the evidence stops, we say so

  • Established biology

    Peptides act as signalling molecules. Uncontroversial.

  • Preclinical work

    Cell culture and animal studies. Most of this literature lives here.

  • Proposed mechanism

    Short chains binding DNA and shifting expression. Argued, not settled.

  • Human evidence

    Thin in English, mostly small, mostly on extracts rather than synthetics.

  • Where it stops

    No claim here about treating, curing, or preventing any disease.

One chain, read left to right

Lys
Glu
Asp

Three residues. That is the whole molecule — the tripeptide sold as Vesugen and studied against endothelial markers. A chain this short may still be read as an instruction by one tissue. Worth reading carefully, not repeating loudly.

The programme

The Short Peptide

A structured reading course on organ-specific bioregulators: the history, the chemistry, the evidence and its limits, and how to tell an extract from a synthetic before you say anything out loud.

The certificate is issued by The Short Peptide. Enrolment is by application. There is no login, no checkout, and no live classroom yet — we will not pretend otherwise.

Syllabus and application

Research summaries, and word when the course opens

Occasional. Study summaries as we publish them, plus one note when enrolment opens.

Who runs the desk

A small editorial group of translators and educators. We are not gerontology principal investigators, and we do not run a laboratory. Our work is reading, checking, and teaching.

About the desk